The key role of the WNT/β-catenin pathway in metabolic reprogramming in cancers under normoxic conditions
A Vallée, Y Lecarpentier, JN Vallée - Cancers, 2021 - mdpi.com
Simple Summary The canonical WNT/β-catenin pathway is upregulated in cancers and
plays a major role in proliferation, invasion, apoptosis and angiogenesis. Recent studies …
plays a major role in proliferation, invasion, apoptosis and angiogenesis. Recent studies …
Therapeutic potential of targeting regulatory mechanisms of hepatic stellate cell activation in liver fibrosis
K Baghaei, S Mazhari, S Tokhanbigli… - Drug discovery today, 2022 - Elsevier
Highlights•Hepatic stellate cell activation/myofibroblast transition is the main driver of liver
fibrosis.•Paracrine signals from adjacent cells induce stellate cell activation.•Alteration in …
fibrosis.•Paracrine signals from adjacent cells induce stellate cell activation.•Alteration in …
[HTML][HTML] Zinc oxide nanoparticles inhibit osteosarcoma metastasis by downregulating β-catenin via HIF-1α/BNIP3/LC3B-mediated mitophagy pathway
G He, JJ Nie, X Liu, Z Ding, P Luo, Y Liu, BW Zhang… - Bioactive Materials, 2023 - Elsevier
Osteosarcoma (OS) therapy faces many challenges, especially the poor survival rate once
metastasis occurs. Therefore, it is crucial to explore new OS treatment strategies that can …
metastasis occurs. Therefore, it is crucial to explore new OS treatment strategies that can …
Targeting Wnt signaling in endometrial cancer
Simple Summary Wnt has diverse regulatory roles at multiple cellular levels and numerous
targeting points, and aberrant Wnt signaling has crucial roles in carcinogenesis, metastasis …
targeting points, and aberrant Wnt signaling has crucial roles in carcinogenesis, metastasis …
Crosstalk between PI3K/AKT/mTOR and WNT/β-Catenin signaling in GBM-Could combination therapy checkmate the collusion?
Glioblastoma multiforme is one of the calamitous primary glial brain tumors with extensive
heterogeneity at cellular and molecular levels. While maximal surgical resection trailed by …
heterogeneity at cellular and molecular levels. While maximal surgical resection trailed by …
Is targeting autophagy mechanism in cancer a good approach? The possible double-edge sword effect
SM Lim, EA Mohamad Hanif, SF Chin - Cell & Bioscience, 2021 - Springer
Autophagy is a conserved cellular process required to maintain homeostasis. The hallmark
of autophagy is the formation of a phagophore that engulfs cytosolic materials for …
of autophagy is the formation of a phagophore that engulfs cytosolic materials for …
Butyrate Inhibits Colorectal Cancer Cell Proliferation through Autophagy Degradation of β-Catenin Regardless of APC and β-Catenin Mutational Status
Colorectal cancer (CRC) pathogenesis is mainly driven by alterations in WNT signaling,
which results in altered transcriptional activity of β-Catenin. Mutations in APC (Adenomatous …
which results in altered transcriptional activity of β-Catenin. Mutations in APC (Adenomatous …
Tanshinone IIA exerts autophagic cell death through down-regulation of β-catenin in renal cell carcinoma cells
NY Kim, YY Jung, MH Yang, A Chinnathambi… - Biochimie, 2022 - Elsevier
Renal cell carcinoma (RCC), also called kidney cancer, is one of the most common
malignancies worldwide, including the United States and China. Because of the …
malignancies worldwide, including the United States and China. Because of the …
[HTML][HTML] Tumor microenvironment involvement in colorectal cancer progression via Wnt/β-catenin pathway: Providing understanding of the complex mechanisms of …
MBN Díaz, MJ Martín, C Gentili - World Journal of …, 2022 - ncbi.nlm.nih.gov
Colorectal cancer (CRC) continues to be one of the main causes of death from cancer
because patients progress unfavorably due to resistance to current therapies. Dysregulation …
because patients progress unfavorably due to resistance to current therapies. Dysregulation …
[HTML][HTML] Targeting LRP6: a new strategy for cancer therapy
W Xue, B Zhu, K Zhao, Q Huang, H Luo, Y Shou… - Pharmacological …, 2024 - Elsevier
Targeting specific molecular drivers of tumor growth is a key approach in cancer therapy.
Among these targets, the low-density lipoprotein receptor-related protein 6 (LRP6), a vital …
Among these targets, the low-density lipoprotein receptor-related protein 6 (LRP6), a vital …